Patents by Inventor Jaime Flores-Riveros

Jaime Flores-Riveros has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bioreactor containers and methods of growing hairy roots using the same
    Patent number: 11299700
    Abstract: Bioreactors and methods of stimulating continuous growth of hairy root biomass in such bioreactors are provided.
    Type: Grant
    Filed: February 19, 2021
    Date of Patent: April 12, 2022
    Assignee: ACEQUIA BIOTECHNOLOGY, LLC
    Inventors: Rocio S. Honigmann, Jaime Flores-Riveros, Martin Sierra-Honigmann
  • COMPOSITIONS AND MANUFACTURE OF MAMMALIAN STEM CELL-BASED COSMETICS
    Publication number: 20130012446
    Abstract: Methods of manufacturing collagen and other extracellular matrix components from SCCs are disclosed. The extracellular matrix components are useful in cosmetic applications, and can be manufactured free of immunogenic concerns and contaminants while controlling for other factors that commonly impact product quality and usefulness.
    Type: Application
    Filed: March 18, 2011
    Publication date: January 10, 2013
    Applicant: AMERSTEM, INC
    Inventors: M. Rocio Sierra-Honigmann, Jaime Flores-Riveros, Martin Sierra
  • Drug screening and treatment methods
    Patent number: 8217025
    Abstract: The invention relates to methods identify or characterize compounds that can be used to treat specified clinical disorders such as hyperglycemia and type 2 diabetes. Compounds that can be used in these methods include 4?-fluoro-17?-ethynylandrost-5-ene-3?,7?,17?-triol, 4?-fluoro-17?-ethynylandrost-5-ene-3?,7?,17?-triol, 4?-fluoro-17?-ethynylandrost-5-ene-3?,7?,17?-triol and 4?-fluoro-17?-ethynylandrost-5-ene-3?,17?-triol-7-one.
    Type: Grant
    Filed: November 19, 2007
    Date of Patent: July 10, 2012
    Assignee: Harbor Therapeutics, Inc.
    Inventors: Jaime Flores-Riveros, James M. Frincke, Christopher Reading, Dwight Stickney, Clarence N. Ahlem
  • Patient populations and treatment methods
    Publication number: 20100222315
    Abstract: The invention provides 17?-ethynylandrost-5-ene-3?, 7?, 17?-triol for use in methods to treat, e.g., hyperglycemia or diabetes patients having a body mass index of at least about 31 (?30.5, ?31 or ?32), wherein the patients are not concurrently treated with metformin and optionally another antidiabetic agent. In these methods, the patient will generally have a fasting insulin level of at least 4 ?U/mL or another characteristic as described herein.
    Type: Application
    Filed: March 25, 2010
    Publication date: September 2, 2010
    Applicant: Harbor BioSciencs, Inc.
    Inventors: Christopher L. Reading, James M. Frincke, Dwight Stickney, Jaime Flores-Riveros
  • Patient populations and treatment methods
    Publication number: 20100075937
    Abstract: The invention provides, inter alia, methods to treat, e.g., hyperglycemia or diabetes patients having two or more of a BMI of at least 28 or 29, a fasting insulin level of at least 4 ?U/mL or at least 6 ?U/mL and optionally (i) a serum MCP1 level of at least about 400 pg/mL or at least about 500 pg/mL. The treatment method includes administering 17?-ethynylandrost-5-ene-3?, 7?, 17?-triol and optionally another compound such as metformin or glyburide. Specific embodiments include use of 17?-ethynylandrost-5-ene-3?, 7?, 17?-triol for the treatment of hypercholesterolemia in a patient and a BMI of at least 28 or 29 and optionally hyperglycemia. In these embodiments, the patient will most preferably have a fasting insulin level of at least 4 ?U/mL or at least 5 ?U/mL.
    Type: Application
    Filed: September 24, 2009
    Publication date: March 25, 2010
    Applicant: Hollis-Eden Pharmaceuticals, Inc.
    Inventors: Jaime Flores-Riveros, James M. Frincke, Christopher L. Reading, Dwight Stickney
  • Drug Screen and Treatment Method
    Publication number: 20080221074
    Abstract: The invention relates to methods identify or characterize compounds that can be used to treat specified clinical disorders such as hyperglycemia and type 2 diabetes. Compounds that can be used in these methods include 4?-fluoro-17?-ethynylandrost-5-ene-3?,7?,17?-triol, 4?-fluoro-17?-ethynylandrost-5-ene-3?,7?,17?-triol, 4?-fluoro-17?-ethynylandrost-5-ene-3?,7?,17?-triol and 4?-fluoro-17?-ethynylandrost-5-ene-3?,17?-triol-7-one.
    Type: Application
    Filed: November 17, 2007
    Publication date: September 11, 2008
    Inventors: Jaime Flores-Riveros, James M. Frincke, Christopher Reading, Dwight Stickney, Clarence Ahlem
  • Drug Screening and Treatment Methods
    Publication number: 20080146532
    Abstract: The invention relates to methods identify or characterize compounds that can be used to treat specified clinical disorders such as hyperglycemia and type 2 diabetes. Compounds that can be used in these methods include 4?-fluoro-17?-ethynylandrost-5-ene-3?, 7?,17?-triol, 4?-fluoro-17?-ethynylandrost-5-ene-3?,7?,17?-triol, 4?-fluoro-17?-ethynylandrost-5-ene-3?,7?,17?-triol and 4?-fluoro-17?-ethynylandrost-5-ene-3?,17?-triol-7-one.
    Type: Application
    Filed: November 19, 2007
    Publication date: June 19, 2008
    Inventors: Jaime Flores-Riveros, James M. Frincke, Christopher Reading, Dwight Stickney, Clarence N. Ahlem
  • Neuropeptide Y receptor Y5 and nucleic acid sequences
    Publication number: 20060189530
    Abstract: The present invention provides novel NPY/PYY receptor proteins and the nucleic acid sequence encoding them. The invention is directed to the isolation, characterization, and pharmacological use of these receptors and nucleic acids. In particular, this invention provides human and rat NPY/PYY receptors (which we call the NPY Y5 receptor) and nucleic acids. Also provided are recombinant expression constructs useful for transfecting cells and expressing the protein in vitro and in vivo. The invention further provides methods for detecting expression levels of the protein as well as methods for screening for receptor antagonists and agonists to be used for the treatment of obesity or anorexia, respectively.
    Type: Application
    Filed: January 19, 2006
    Publication date: August 24, 2006
    Inventors: Yinghe Hu, Michael McCaleb, Brian Bloomquist, Jaime Flores-Riveros, Linda Cornfield
  • Regulated expression of recombinant DNA
    Publication number: 20030113784
    Abstract: This invention relates to regulatable recombinant expression constructs that provide regulated gene expression of mammalian genes.
    Type: Application
    Filed: November 27, 2002
    Publication date: June 19, 2003
    Inventors: Jaime Flores-Riveros, Jean Adamus, Grazia Ambrosini